George R. Brown Convention Center
1001 Avenida de las Americas
Houston, Texas 77010
Room 351
Don't miss this opportunity to gain insights into groundbreaking approaches for the treatment of leptomeningeal metastasis!
Presented by Plus Therapeutics at the SNO Annual Conference, this session will delve into cutting-edge radiation-based therapies for leptomeningeal metastasis (LM). It will feature expert presentations along with a panel discussion with audience Q&A aimed at exploring the latest advances in the treatment of LM.
Agenda:
Moderated by:
Priya Kumthekar, M.D.
Associate Professor of Neurology and Medicine
Lou and Jean Malnati Brain Tumor Institute
Northwestern University
12:45-1:05pm
Radiation base therapeutic approaches to LM
Jonathan T. Yang, MD, PhD
Director, Clinical Research, Brain and Spine Tumor Center
Laura and Isaac Perlmutter Cancer Center
NYU Langone
1:05-1:25pm
Direct intrathecal delivery of radionuclides to the CSF for LM and the future of LM treatment
Andrew Brenner, MD, PhD,
Professor-Research, Departments of Medicine, Neurology, and Neurosurgery
Clinical Investigator, Institute for Drug Development
Co-Leader, Experimental and Developmental Therapeutics Program
S & B Kolitz/CTRC-Zachry Endowed Chair for Neuro-Oncology Research
Mays Cancer Center at UT Health San Antonio
1:25-1:45pm
Panel Discussion and Q&A
